Translational Development Acquisition TDAC
NASDAQ TDAC
$10.84 +0.00 (+0.00%)
As of: Aug 21, 2026 · 9:53 AM EDT

Translational Development Acquisition (TDAC) Notes Payables (2023 - 2026)

Translational Development Acquisition's (TDAC) quarterly Notes Payables came in at $500000.0 in Q1 2026, up 150.0% on a QoQ basis from $200000.0 in Q4 2025.

Translational Development Acquisition (TDAC) Notes Payables (2023 - 2026) Analysis & Trends

Translational Development Acquisition (TDAC) has 3 years of Notes Payables data on file, last reported at $500000.0 in Q1 2026.

  • Quarterly Notes Payables changed N/A year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $500000.0 (changed N/A YoY) and the FY2025 annual result came in at $200000.0, changed N/A from the prior year.
  • Notes Payables climbed to $500000.0 in Q1 2026, from $200000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $500000.0 in Q1 2026 to a low of $100000.0 in Q3 2025.
  • A 3-year average of $286875.0 and a median of $273750.0 in 2023 frame the typical range for Notes Payables.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn -
2 Launch Two Acquisition 557.86 Mn 557.86 Mn -
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn -
4 Cantor Equity Partners IV 467.55 Mn 467.55 Mn -
5 New Providence Acquisition Corp. III 401.18 Mn 401.18 Mn -
6 GP-Act III Acquisition 401.06 Mn 401.06 Mn -
7 Aldel Financial 397.49 Mn 397.49 Mn -
8 Pioneer Acquisition I 390.89 Mn 653.32 Mn -
9 Republic Digital Acquisition 389.25 Mn 388.51 Mn -
10 Translational Development Acquisition 182.66 Mn 182.57 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Dec 31, 2023 347,500.00